Quality assurance in human papillomavirus testing for primary cervical screening
Kate Cuschieri, Marı́a Dolores Fellner, Laila Sara Arroyo Mühr, Elizaveta Padalko, Rita Mariel Correa, Joakim Dillner, Murat Gültekin, Marı́a Alejandra Picconi
Abstract
The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential.